Total Payments
$1,403
2024 Payments
$745.50
Companies
23
Transactions
61
Medicare Patients
7,660
Medicare Billing
$525,519
Payment Breakdown by Category
Food & Beverage$1,403 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,403 | 61 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $194.42 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $192.86 | 11 | $0 (2024) |
| Boston Scientific Corporation | $185.62 | 7 | $0 (2024) |
| Philips North America LLC | $114.31 | 7 | $0 (2024) |
| MEDICOMP INC | $73.35 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $71.55 | 4 | $0 (2024) |
| Amgen Inc. | $61.69 | 3 | $0 (2024) |
| BIOTRONIK INC. | $61.18 | 3 | $0 (2019) |
| iRhythm Technologies, Inc. | $55.94 | 3 | $0 (2020) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $45.09 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $745.50 | 35 | Novartis Pharmaceuticals Corporation ($173.26) |
| 2023 | $191.34 | 9 | Boston Scientific Corporation ($98.75) |
| 2022 | $53.41 | 3 | Boston Scientific Corporation ($21.43) |
| 2021 | $95.36 | 4 | Shockwave Medical, Inc ($39.15) |
| 2020 | $52.90 | 3 | iRhythm Technologies, Inc. ($20.52) |
| 2019 | $111.93 | 6 | BIOTRONIK INC. ($61.18) |
| 2017 | $152.77 | 1 | Abbott Laboratories ($152.77) |
All Payment Transactions
61 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.02 | General |
| Category: Cardiovascular | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | Philips North America LLC | (5050) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $18.34 | General |
| Category: Medical Device | ||||||
| 11/01/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.74 | General |
| Category: Cardiovascular | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | Abbott Laboratories | ASSURITY (Device) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/24/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $15.18 | General |
| Category: Medical Device | ||||||
| 09/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Obesity | ||||||
| 09/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Cardiology | ||||||
| 09/16/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $6.33 | General |
| Category: Medical Device | ||||||
| 09/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.17 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/10/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $17.38 | General |
| Category: Medical Device | ||||||
| 07/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: Cardio-renal | ||||||
| 07/09/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: WATCHMAN_IC | ||||||
| 06/27/2024 | Philips North America LLC | (5050) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $17.81 | General |
| Category: Medical Device | ||||||
| 06/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Diabetes | ||||||
| 05/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/17/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.48 | General |
| Category: Cardiovascular | ||||||
| 05/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/07/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $19.76 | General |
| Category: Medical Device | ||||||
| 04/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.31 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,850 | 2,275 | $582,209 | $148,063 |
| 2022 | 27 | 3,569 | 4,346 | $1.0M | $278,262 |
| 2021 | 23 | 1,122 | 1,236 | $180,276 | $47,687 |
| 2020 | 26 | 1,119 | 1,240 | $226,795 | $51,507 |
Total Patients
7,660
Total Services
9,097
Medicare Billing
$525,519
Procedure Codes
121
All Medicare Procedures & Services
121 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 297 | 404 | $124,352 | $32,980 | 26.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 92 | 92 | $130,180 | $30,486 | 23.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 109 | 110 | $63,016 | $13,852 | 22.0% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 58 | 115 | $23,000 | $9,913 | 43.1% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 61 | 244 | $30,900 | $8,630 | 27.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 193 | 194 | $47,800 | $8,261 | 17.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 69 | 69 | $25,864 | $7,511 | 29.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 88 | 109 | $18,096 | $6,383 | 35.3% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 27 | 27 | $23,026 | $4,952 | 21.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 102 | 102 | $19,608 | $4,697 | 24.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 47 | 47 | $7,278 | $3,723 | 51.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 290 | 329 | $16,710 | $2,973 | 17.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 22 | 22 | $8,734 | $2,964 | 33.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 50 | 50 | $11,911 | $2,395 | 20.1% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 37 | 37 | $5,913 | $1,979 | 33.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 29 | $4,089 | $1,782 | 43.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 15 | $3,060 | $1,386 | 45.3% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 59 | 59 | $4,393 | $824.15 | 18.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 59 | 59 | $3,798 | $569.61 | 15.0% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 23 | 23 | $1,965 | $435.67 | 22.2% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 20 | 20 | $1,420 | $390.72 | 27.5% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 36 | 36 | $3,241 | $350.46 | 10.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 21 | 24 | $480.00 | $201.60 | 42.0% |
| 93270 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | Office | 2023 | 28 | 28 | $1,360 | $151.52 | 11.1% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 13 | 13 | $845.00 | $144.69 | 17.1% |
About Dr. Gregory Pellizzon, M.D
Dr. Gregory Pellizzon, M.D is a Interventional Cardiology healthcare provider based in Fredericksburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1932190345.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Pellizzon, M.D has received a total of $1,403 in payments from pharmaceutical and medical device companies, with $745.50 received in 2024. These payments were reported across 61 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,403).
As a Medicare-enrolled provider, Pellizzon has provided services to 7,660 Medicare beneficiaries, totaling 9,097 services with total Medicare billing of $525,519. Data is available for 4 years (2020–2023), covering 121 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Cardiovascular Disease
- Location Fredericksburg, VA
- Active Since 11/03/2005
- Last Updated 11/15/2023
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1932190345
Products in Payments
- LEQVIO (Drug) $162.20
- Cardiovascular-Research only (Device) $152.77
- (5044) MCOT (Device) $76.96
- TELEPATCH CARDIAC MONITOR (Device) $73.35
- CAMZYOS (Drug) $71.55
- Repatha (Biological) $61.69
- ZIO Patch (Device) $55.94
- (5050) Extended Holter (Device) $55.66
- LifeVest (Device) $45.09
- Varithena Administration Pack (Device) $44.81
- Vascular Lithotripsy (Device) $39.15
- VERQUVO (Drug) $33.63
- Venclose Maven Catheter (Device) $32.26
- ENTRESTO (Drug) $30.66
- CLOSUREFAST (Device) $30.64
- BRILINTA (Drug) $27.09
- Wegovy (Drug) $23.66
- Kerendia (Drug) $23.15
- ASSURITY (Device) $23.12
- OptiCross (Device) $21.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Fredericksburg
Dr. Rajiv Tayal, M.d., M.p.h, M.D., M.P.H
Interventional Cardiology — Payments: $980,411
Interventional Cardiology $980,411
Thomas Martyak, Md, MD
Interventional Cardiology — Payments: $70,781
Interventional Cardiology $70,781
Zeshan Rana, M.d, M.D
Interventional Cardiology — Payments: $28,759
Interventional Cardiology $28,759
Ashok Prasad, M.d, M.D
Interventional Cardiology — Payments: $11,174
Interventional Cardiology $11,174
Thomas Wheeler, Md, MD
Interventional Cardiology — Payments: $4,511
Interventional Cardiology $4,511
Scott Seidner, M.d, M.D
Interventional Cardiology — Payments: $281.44
Interventional Cardiology $281.44